Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Denise Pretzer is active.

Publication


Featured researches published by Denise Pretzer.


Pharmaceutical Research | 1992

Effect of zinc binding on the structure and stability of fibrolase, a fibrinolytic protein from snake venom.

Denise Pretzer; Brenda Schulteis; David Vander Velde; Christopher Smith; James W. Mitchell; Mark C. Manning

Fibrolase is a metalloprotease with potential use as a fibrinolytic agent. Loss of the intrinsic zinc atom leads to a rapid decrease in enzymatic activity. Circular dichroism measurements indicate that there is a partial unfolding of an α-helical section of the protein concomitant with the loss of zinc. Removal of zinc can be affected by elevated temperatures, acidic pH values, and addition of chelating agents. At low molar concentrations, both ethylenediaminetet-raacetic acid (EDTA) and dithiothreitol (DTT) were found to remove zinc efficiently. Analysis of the sequence of fibrolase identified a segment which possessed a high degree of homology with the metal binding site of other zinc proteases, such as thermolysin and the collagenases. However, the putative zinc binding site in fibrolase lacks the additional glutamate ligand found in thermolysin and subtilisin. This sequence is also predicted to adopt an α-helical conformation. Together, these data indicate that there is a well-defined metal binding site in fibrolase and that metal binding is the most important factor governing the stability of this protein.


Pharmaceutical Research | 1991

Stability of the Thrombolytic Protein Fibrolase: Effect of Temperature and pH on Activity and Conformation

Denise Pretzer; Brenda Schulteis; Christopher Smith; David Vander Velde; James W. Mitchell; Mark C. Manning

The effect of temperature and pH on the activity and conformation of the thrombolytic protein fibrolase was examined. Fibrolase maintained proteolytic activity over 10 days at room temperature (∼22°C). At 37°C, greater than 50% of the proteolytic activity was lost within 2 days and no activity remained after 10 days. Circular dichroism (CD) spectra at elevated temperatures showed that alphahelical structure was lost in a cooperative transition (Tm of 50°C at pH 8). Structural changes were detected by NMR prior to unfolding which were not observable by CD, and the Tm determined by NMR was 46°C at pD 8. The effect of pH on the proteolytic activity and structure of fibrolase was examined over the pH range from 1 to 10. Activity was maintained at neutral to alkaline pH values from pH 6.5 to pH 10.0 but decreased substantially in acidic media. While CD spectra indicated little variation in secondary structure over the pH range 5 to 9, significant differences were noted at pH 2 to 3. The melting temperature of fibrolase decreased to 43°C at pH 5. Protein concentrations determined over the pH range 1 to 10 showed an apparent solubility minimum at pH 5.0, which did not correspond to the isoelectric point of 6.5. Explanations for these observations are proposed.


Archive | 1995

Oral liquid alendronate formulations

Gerald S. Brenner; Ashok V. Katdare; Denise Pretzer; Donna T Whiteford


Archive | 1996

Oral liquid alendronaattikokoonpanoja

Gerald S. Brenner; Ashok V. Katdare; Denise Pretzer; Donna T Whiteford


Archive | 1996

Oraalisia nestemäisiä alendronaattikokoonpanoja

Gerald S. Brenner; Ashok V. Katdare; Denise Pretzer; Donna T Whiteford


Archive | 1995

Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat

S Brenner; V Katdare; Denise Pretzer; T Whiteford


Archive | 1995

Oral liquid alendronatformuleringer

Ashok V. Katdare; Gerald S. Brenner; Denise Pretzer; Donna T Whiteford


Archive | 1995

Formulations d'alendronate liquide a absorption orale

Gerald S. Brenner; Ashok V. Katdare; Denise Pretzer; Donna T Whiteford


Archive | 1995

Oral liquid formulations of alendronate.

Gerald S. Brenner; Ashok V. Katdare; Denise Pretzer; Donna T Whiteford


Archive | 1995

Orale, væskeformige alendronatformuleringer

Ashok V. Katdare; Gerald S. Brenner; Denise Pretzer; Donna T Whiteford

Collaboration


Dive into the Denise Pretzer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark C. Manning

Colorado State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge